by SCIEX Community | Mar 18, 2016 | Biopharma, Blogs
Since the 1982 approval of Eli Lilly’s recombinant human insulin, Humulin, biotherapeutic drug development has steadily grown into a global market valued at $140 billion in 2013, increased from $25 billion in 20011 (Table 1). Biologics, or biotherapeutics, make up a...
by Christie Hunter | Mar 18, 2016 | Blogs, Life Science Research
Calling all SWATH® Acquisition users! If you have a TripleTOF® System and you’re using SWATH Acquisition for your quantitative proteomics experiments, you’ve made the right choice. SWATH is a data independent workflow that enables data to be acquired for every...
by SCIEX Community | Mar 16, 2016 | Biopharma, Blogs
Last week we posted a blog on Biologics Bioanalysis Key Challenges, where we presented a webinar on those key challenges. Here are the follow-up questions that were received: 1. You mentioned immunocapture-based sample preparation is more automation friendly. Could...
by SCIEX Community | Mar 7, 2016 | Blogs, Environmental / Industrial, Food / Beverage
Access to clean wholesome water is one of our basic human rights. Human engineering has designed incredible methods to collect, filter, purify, store and distribute water to billions of us worldwide, but does this mean that our water is completely safe to drink? Also,...
by SCIEX Community | Feb 29, 2016 | Biopharma, Blogs
Traditionally, the pharmacokinetic profile of biotherapeutics such as insulin glargine, adalimumab, trastuzumab and others, used gold standard LBAs to assess dose-response during drug discovery and development. However, LBAs require a specific antibody reagent to be...